Paul Lytle
Vermögen: 635 166 $ am 31.05.2026
Vermögen: 635 166 $ am 31.05.2026
Paul J.
Lytle was the founder of Mosaic ImmunoEngineering, Inc., founded in 1992, where the titles held included Chief Financial Officer, Secretary, Director & EVP.
Mr. Lytle is the founder of Mosaic ImmunoEngineering Development Co., founded in 2020, holding the titles of Chief Financial Officer, Director & Executive VP.
Mr. Lytle is the founder of Thendor Therapeutics LLC, founded in 2023, serving as Chief Financial Officer.
Current jobs include Member at The American Institute of Certified Public Accountants and Chief Financial & Accounting Officer at Actuate Therapeutics, Inc. since 2024.
Former jobs include Director at Patriot Scientific Corp.
in 2020, Chief Financial Officer at Avid Bioservices, Inc. from 2002 to 2018, Chief Financial Officer & Executive Vice President at Breathe Technologies, Inc. from 2018 to 2019, and Principal at Deloitte & Touche LLP.
Education includes undergraduate studies at The California State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2025 | 1’641’252 ( 22.66% ) | 635 165 $ | 31.05.2026 | |
| 21.08.2020 | 161’000 ( 25.56% ) | 2 $ | 31.08.2020 | |
| 01.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.02.2024 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Mosaic ImmunoEngineering Development Co.
Mosaic ImmunoEngineering Development Co. BiotechnologyHealth Technology Develops novel immunotherapies to treat and prevent cancer and infectious diseases | Gründer | 01.08.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
Breathe Technologies, Inc.
Breathe Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures chronic obstructive pulmonary disease therapy devices | Finanzdirektor/CFO | 01.12.2019 |
| AVID BIOSERVICES, INC. | Finanzdirektor/CFO | 24.05.2018 |
| MOSAIC IMMUNOENGINEERING, INC. | Gründer | - |
| PATRIOT SCIENTIFIC CORPORATION | Finanzdirektor/CFO | - |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Avid Bioservices, Inc.
Avid Bioservices, Inc. Pharmaceuticals: MajorHealth Technology Engages in the developing and manufacturing of biologics | Health Technology |
Patriot Scientific Corp.
Patriot Scientific Corp. SemiconductorsElectronic Technology Develops microprocessors | Electronic Technology |
Breathe Technologies, Inc.
Breathe Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures chronic obstructive pulmonary disease therapy devices | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avid Bioservices, Inc. /Old/
Avid Bioservices, Inc. /Old/ Medical/Nursing ServicesHealth Services Provides highly specialized cell cultures for biotechnology testing | Health Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
Mosaic ImmunoEngineering Development Co.
Mosaic ImmunoEngineering Development Co. BiotechnologyHealth Technology Develops novel immunotherapies to treat and prevent cancer and infectious diseases | Health Technology |
Mosaic ImmunoEngineering, Inc.
Mosaic ImmunoEngineering, Inc. BiotechnologyHealth Technology Develops immunotherapy pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen